Although the incidence of Pneumocystis pneumonia (PCP) has decreased since the
introduction of combination antiretroviral therapy, it remains an important cause of disease in …

The substantial decline in the Pneumocystis jirovecii pneumonia (PCP) incidence in HIV-
infected patients after the introduction of antiretroviral therapy (ART) in resource-rich settings …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

Pneumocystis jirovecii pneumonia (PCP) in patients without AIDS is increasingly common.
We conducted a prospective cohort study of consecutive patients with proven PCP; of 544 …

Objective To determine the clinical spectrum of immunosuppressive conditions and systemic
corticosteroid therapy associated with the development of Pneumocystis carinii pneumonia …

Pneumocystis carinii pneumonia is the most common opportunistic infection in AIDS1, and
accounts for significant morbidity and mortality in these and other immunocompromised …

In the next decade, longer survival of patients with cancer and more-aggressive therapies
applied to common conditions, such as asthma and rheumatoid arthritis, will result in a …

Background Pneumocystis jirovecii pneumonia (PCP) causes substantive morbidity in
immunocompromised patients. The EORTC/MSGERC convened an expert group to …

OBJECTIVE. The purpose of this essay is to review the spectrum of high-resolution CT
findings of Pneumocystis jiroveci pneumonia in immunocompromised patients with and …